Weill Cornell Medicine on the Upper East Side seeks a Lead in TIL Reprogramming to oversee a focused team advancing next-generation TIL therapies. This role drives reprogramming and optimization of TILs for enhanced potency, persistence, and clinical efficacy, translating insights into scalable, IND-ready cell therapy candidates.
The successful candidate will mentor a multidisciplinary team, define target product profiles, and coordinate IND documentation while collaborating with process
#J-18808-LjbffrLead TIL Reprogramming for Next-Gen Immunotherapies in new york at Unknown Company
This position is listed as full time and onsite.